Gilder Gagnon Howe & Co’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5
| Closed | – | – | 366 |
|
|
2020
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 357 |
|
|
2020
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 327 |
|
|
2020
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 313 |
|
|
2019
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 315 |
|
|
2019
Q3 | $0 | Sell |
5
-29,475
| -100% | – | ﹤0.01% | 312 |
|
|
2019
Q2 | $389K | Buy |
+29,480
| New | +$389K | ﹤0.01% | 250 |
|